版本:
中国

BRIEF-FDA grants Ignyta breakthrough therapy designation for entrectinib

May 15 Ignyta Inc

* Ignyta granted breakthrough therapy designation for entrectinib by U.S. Food and Drug Administration Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐